metoprolol has been researched along with Chronic Kidney Diseases in 9 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is little evidence guiding selection of nondiuretic, antihypertensive agents with a goal of lowering uric acid (SUA) and minimizing gout risk." | 9.24 | Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. ( Appel, LJ; Juraschek, SP; Miller, ER, 2017) |
| "There is little evidence guiding selection of nondiuretic, antihypertensive agents with a goal of lowering uric acid (SUA) and minimizing gout risk." | 5.24 | Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. ( Appel, LJ; Juraschek, SP; Miller, ER, 2017) |
| "Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol." | 3.91 | Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019) |
| " The new model is useful for estimating the risk of drug interaction in clinical practice when AST-120 is used in combination with other drugs." | 1.43 | Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs. ( Kotegawa, T; Koya, Y; Machi, Y; Namiki, N; Shobu, Y; Uchida, S, 2016) |
| "Atenolol treatment initiation was associated with lower 90-day risk of mortality than metoprolol tartrate (incidence, 0." | 1.40 | Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults. ( Devereaux, PJ; Fleet, JL; Garg, AX; Jain, AK; McArthur, E; Ozair, S; Roberts, MA; Weir, MA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sessa, M | 1 |
| Mascolo, A | 1 |
| Rasmussen, DB | 1 |
| Kragholm, K | 1 |
| Jensen, MT | 1 |
| Sportiello, L | 1 |
| Rafaniello, C | 1 |
| Tari, GM | 1 |
| Pagliaro, C | 1 |
| Andersen, M | 1 |
| Rossi, F | 1 |
| Capuano, A | 1 |
| Schlosser, P | 1 |
| Li, Y | 1 |
| Sekula, P | 1 |
| Raffler, J | 1 |
| Grundner-Culemann, F | 1 |
| Pietzner, M | 1 |
| Cheng, Y | 1 |
| Wuttke, M | 1 |
| Steinbrenner, I | 1 |
| Schultheiss, UT | 1 |
| Kotsis, F | 1 |
| Kacprowski, T | 1 |
| Forer, L | 1 |
| Hausknecht, B | 1 |
| Ekici, AB | 1 |
| Nauck, M | 1 |
| Völker, U | 1 |
| Walz, G | 1 |
| Oefner, PJ | 1 |
| Kronenberg, F | 1 |
| Mohney, RP | 1 |
| Köttgen, M | 1 |
| Suhre, K | 1 |
| Eckardt, KU | 1 |
| Kastenmüller, G | 1 |
| Köttgen, A | 1 |
| Juraschek, SP | 1 |
| Appel, LJ | 1 |
| Miller, ER | 1 |
| Assimon, MM | 1 |
| Brookhart, MA | 1 |
| Fine, JP | 1 |
| Heiss, G | 1 |
| Layton, JB | 1 |
| Flythe, JE | 1 |
| Khatir, DS | 1 |
| Pedersen, M | 1 |
| Ivarsen, P | 1 |
| Christensen, KL | 1 |
| Jespersen, B | 1 |
| Buus, NH | 1 |
| Fleet, JL | 1 |
| Weir, MA | 1 |
| McArthur, E | 1 |
| Ozair, S | 1 |
| Devereaux, PJ | 1 |
| Roberts, MA | 1 |
| Jain, AK | 1 |
| Garg, AX | 1 |
| Randhawa, SK | 1 |
| Elliott, WJ | 1 |
| Koya, Y | 1 |
| Uchida, S | 1 |
| Machi, Y | 1 |
| Shobu, Y | 1 |
| Namiki, N | 1 |
| Kotegawa, T | 1 |
| Al-Ramahi, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| African American Study of Kidney Disease and Hypertension ABPM Pilot Study[NCT00582777] | Phase 2/Phase 3 | 180 participants (Anticipated) | Interventional | 2007-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for metoprolol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Antihypertensive Agents; Biomarkers; Black or African | 2017 |
Effects of additional vasodilatory or nonvasodilatory treatment on renal function, vascular resistance and oxygenation in chronic kidney disease: a randomized clinical trial.
Topics: Amlodipine; Angiotensins; Antihypertensive Agents; Disease Progression; Glomerular Filtration Rate; | 2019 |
7 other studies available for metoprolol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol | 2019 |
Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.
Topics: Acetyltransferases; Alkaline Phosphatase; Biomarkers; Biotransformation; Cohort Studies; Cytochrome | 2020 |
A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Carvedilol; Cohort Studies; Female; Humans; Male; Meto | 2018 |
Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atenolol; Coh | 2014 |
Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Female; Humans; Kidney; Male; Metoprolol; Populati | 2014 |
Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs.
Topics: Administration, Oral; Adsorption; Aluminum Hydroxide; Amlodipine; Aspirin; Carbon; Drug Interactions | 2016 |
Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Calcium Carbonate; Chi-Square Distribution; Die | 2012 |